2m 2m 2m 2m 2m 2m 2m
CAMP4 THERAP (CAMP)
NASDAQ
$4.05+$0.21 (+5.42%)
Price as of Oct 02, 2026 4:59 PM EDT- $241.0MMarket Cap
- 28.86%1-Year Change
- BiotechnologyIndustry
CAMP4 THERAP (CAMP)
$4.05+$0.21 (+5.42%)
CAMP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.84 | ||
Change | -$0.20 (-4.95%) | ||
Open | $3.99 | ||
High | $4.15 | ||
Low | $3.76 | ||
Previous Close | $4.04 | ||
Volume | 994,722 | ||
30-Day Average Volume | 314,516 | ||
1-Week Change | 0.00% | ||
1-Month Change | 1.32% | ||
1-Year Change | 28.86% | ||
3-Year Change | -58.84% | ||
5-Year Change | -98.37% | ||
Fundamentals | |||
Shares Outstanding | 62.8M | ||
Total Assets | $93.4M | ||
Market Cap | $241.0M | ||
Enterprise Value | $154.6M | ||
Period: QTR TTM FY | |||
Revenue | $1.8M | ||
Net Income | -$33.5M | ||
Free Cash Flow | -$12.8M | ||
EBIT | -$33.5M | ||
EBITDA | -$33.0M | ||
Net Working Capital | $70.9M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | 87 | ||
P/B | -348 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 23 | ||
Last Split Date | 02/02/2024 | ||
Earnings & Revenue